C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2002
10/24/2002	WO2002083955A1 Methods and compositions for nucleotide analysis
10/24/2002	WO2002083954A1 Mobility-modified nucleobase polymers and methods of using same
10/24/2002	WO2002083953A1 Methods for identifying small molecules that bind specific rna structural motifs
10/24/2002	WO2002083952A1 Systems and methods for high throughput genetic analysis
10/24/2002	WO2002083950A1 Methods and compositions for treating cardiovascular disease using 10218
10/24/2002	WO2002083949A1 A method for detecting hybridized nucleic acid with improved sensitivity
10/24/2002	WO2002083948A1 Oligonucleotide chip composition for analyzing hepatitis c virus (hcv) genotype and detecting method thereof
10/24/2002	WO2002083946A1 Method of examining allergic disease
10/24/2002	WO2002083945A2 Diagnosis and treatment of cancer: i
10/24/2002	WO2002083944A2 Chemical compounds for identification of slc10a2 gene polymorphisms
10/24/2002	WO2002083943A2 Microarray method for enriching dna fragments from complex mixtures
10/24/2002	WO2002083942A2 Method and device for determining and selecting molecule-molecule interactions
10/24/2002	WO2002083941A2 Highly specific detection system for detecting nucleotide sequences coding for lambda and kappa light chains
10/24/2002	WO2002083940A2 Screening method for anti-microbial drug targets by genome-saturing mutagenesis (gsm)
10/24/2002	WO2002083939A2 Controllable increase in the sensitivity of hybridisation detection
10/24/2002	WO2002083938A2 Screening methods for identifying ligands
10/24/2002	WO2002083937A2 Methods using o6-alkylguanine-dna alkyltransferases
10/24/2002	WO2002083936A2 Novel method for screening inhibitors of the linkage between the neuronal nitric oxide synthase associated protein and the protein inhibiting neuronal nitric oxide synthase
10/24/2002	WO2002083935A1 Method for calibrating antibiotic disk diffusion testings of microorganisms
10/24/2002	WO2002083934A1 P2yac receptor involved in platelet aggregation
10/24/2002	WO2002083933A2 Method for determining the substrate specificity of an enzymatic activity and a device therefor
10/24/2002	WO2002083932A2 Enzymatic degradation chains
10/24/2002	WO2002083931A2 Method for fixing biomolecules onto chemically inert surfaces
10/24/2002	WO2002083930A2 Immersion sensor for measuring the concentration of an analyte with the help of an oxidase
10/24/2002	WO2002083929A2 System and method for quantitating transcription factors
10/24/2002	WO2002083928A2 Nucleid acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer
10/24/2002	WO2002083927A2 Universal multi-variant detection system
10/24/2002	WO2002083922A2 Modified random primers for probe labeling
10/24/2002	WO2002083921A2 Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
10/24/2002	WO2002083919A2 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
10/24/2002	WO2002083917A2 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer
10/24/2002	WO2002083916A2 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
10/24/2002	WO2002083912A2 Production of apomictic seed
10/24/2002	WO2002083903A2 West nile virus epitopes and uses thereof
10/24/2002	WO2002083898A1 Full-length human cdnas encoding potentially secreted proteins
10/24/2002	WO2002083894A1 Linear nucleic acid sequence comprising repeats and lacking secondary structure
10/24/2002	WO2002083893A2 Isolation of dna molecules using mercapto-aryl ligands
10/24/2002	WO2002083882A2 Regulation of human serine/threonine protein kinase-like protein
10/24/2002	WO2002083881A1 Methods for detecting and adjusting replication of hepatitis b virus and for preparing mutated virus strains with altered replication efficiency
10/24/2002	WO2002083873A2 Enzymes
10/24/2002	WO2002083872A2 Methods and products of cleaving ssdna using oligonucleotides to form restriction sites
10/24/2002	WO2002083870A2 Pufa polyketide synthase systems and uses thereof
10/24/2002	WO2002083868A2 Peroxide-driven cytochrome p450 oxygenase variants
10/24/2002	WO2002083867A2 Ires enabled gene trapping in plants
10/24/2002	WO2002083866A2 Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions
10/24/2002	WO2002083862A2 Methods and compositions for identifying disease genes using nonsense-mediated decay inhibition
10/24/2002	WO2002083860A2 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer
10/24/2002	WO2002083859A2 Surface proteins of streptococcus pyogenes
10/24/2002	WO2002083855A2 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
10/24/2002	WO2002083853A2 Method for enhancing the translation and expression of recombinant proteins
10/24/2002	WO2002083852A2 Microfermentor device and cell based screening method
10/24/2002	WO2002083847A2 Cdna encoding the human alpha2 delta4 calcium channel subunit
10/24/2002	WO2002083846A2 Methods of analysis and labeling of protein-protein interactions
10/24/2002	WO2002083843A2 Outer membrane associated polypeptides
10/24/2002	WO2002083841A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/24/2002	WO2002083839A2 P450 single nucleotide polymorphism biochip analysis
10/24/2002	WO2002083838A2 Elimination of endogenous porcine retrovirus
10/24/2002	WO2002083837A1 Methods for identifying small molecules that bind specific rna structural motifs
10/24/2002	WO2002083822A2 Solid lubricant and composition
10/24/2002	WO2002083721A1 Protein cluster v
10/24/2002	WO2002083720A2 Intermediates and enzymes of the non-mevalonate isoprenoid pathway
10/24/2002	WO2002083712A2 Transporters and ion channels
10/24/2002	WO2002083709A2 Kinases and phosphatases
10/24/2002	WO2002083705A1 Socs-1 gene methylation in cancer
10/24/2002	WO2002083081A2 Prostate cancer-related compositions, methods and kits based on dna macroarray protemics platforms
10/24/2002	WO2002083077A2 Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease
10/24/2002	WO2002083064A2 A method of treating cancer
10/24/2002	WO2002083060A2 Use of amino acid transporter atb0,+ as a delivery system for drugs and prodrugs
10/24/2002	WO2002082969A2 Diagnostics and therapeutics for glaucoma, retinal degenerative diseases and cardiovascular diseases based on novel nucleic acids and protein forms of myocilin (myoc)
10/24/2002	WO2002082898A1 Novel endophytic fungi and methods of use
10/24/2002	WO2002074941A8 Reporter virus comprising heterologous envelope proteins
10/24/2002	WO2002065091A3 Pin1 as marker for abnormal cell growth
10/24/2002	WO2002064618A9 Methods of identifying agents that mediate polypeptide aggregation
10/24/2002	WO2002064023A3 Fra-1 expression in brain cancer
10/24/2002	WO2002064015A8 Pin1 as a marker for prostate cancer
10/24/2002	WO2002060931A3 A fimbria-like gene in bifidobacteria
10/24/2002	WO2002055669A3 Regulation of target protein activity through modified proteins
10/24/2002	WO2002046367A3 Antisense modulation of cellular apoptosis susceptibility gene expression
10/24/2002	WO2002045570A9 Methods and compositions for the diagnosis and treatment of viral disease using 55092
10/24/2002	WO2002045524A3 Prolyl endoprotease from aspergillus niger
10/24/2002	WO2002040715A8 Molecules for disease detection and treatment
10/24/2002	WO2002038540A3 Activity-dependent cysteine protease profiling reagent
10/24/2002	WO2002032397A9 Electroprocessing in drug delivery and cell encapsulation
10/24/2002	WO2002026958A3 Human neprilysin protease
10/24/2002	WO2002006462A3 Methylated nucleotide regulation of upa gene expression
10/24/2002	WO2002002803A3 Method for formulating molecular probes
10/24/2002	WO2002000913A9 MODULATION OF β-AMYLOID LEVELS BY β-SECRETASE BACE2
10/24/2002	WO2001077375A8 Diagnosis of diseases associated with gene regulation
10/24/2002	WO2001071036A3 Methods of preparing amplified nucleic acid molecules
10/24/2002	WO2001068911A8 Diagnosis of diseases associated with the cell cycle
10/24/2002	WO2001064861A3 Phosphoribosyl pyrophosphate synthetase 1 as herbicidal target
10/24/2002	WO2001062975A9 Pyrophosphorolysis activated polymerization (pap): application to allele-specific amplification and nucleic acid sequence determination
10/24/2002	WO2001062793A9 Estrogen receptor beta variants and methods of detection thereof
10/24/2002	WO2001059103A9 Method and reagent for the modulation and diagnosis of cd20 and nogo gene expression
10/24/2002	WO2001059073A9 Cytotoxic t lymphocytes activated by dendritic cell hybrids
10/24/2002	WO2001057189A9 Fas pathway genes
10/24/2002	WO2001055720A9 A system for developing assays for personalized medicine
10/24/2002	WO2001055337A3 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides
10/24/2002	WO2001053537A3 Nitric oxide synthase gene diagnostic polymorphisms
10/24/2002	WO2001053529A9 RAPID DETERMINATION OF GENE STRUCTURE USING cDNA SEQUENCE

1 ... 2222 2223 2224 2225 2226 2227 2228 2229 2230 2231 2232 2233 2234 2235 2236 2237 2238 2239 2240 2241 2242 ... 3003